Terms: = Lymphoma AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
5167 results:
1. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
[TBL] [Abstract] [Full Text] [Related]
2. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Risk Factors Collaborators
Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.
Kwak K; Park Y; Kim BS; Kang KW
Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
[TBL] [Abstract] [Full Text] [Related]
5. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
[TBL] [Abstract] [Full Text] [Related]
6. Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Callander NS; Silbermann R; Kaufman JL; Godby KN; Laubach J; Schmidt TM; Sborov DW; Medvedova E; Reeves B; Dhakal B; Rodriguez C; Chhabra S; Chari A; Bal S; Anderson LD; Dholaria BR; Nathwani N; Hari P; Shah N; Bumma N; Holstein SA; Costello C; Jakubowiak A; Wildes TM; Orlowski RZ; Shain KH; Cowan AJ; Pei H; Cortoos A; Patel S; Lin TS; Giri S; Costa LJ; Usmani SZ; Richardson PG; Voorhees PM
Blood Cancer J; 2024 Apr; 14(1):69. PubMed ID: 38649340
[TBL] [Abstract] [Full Text] [Related]
7. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators
Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
[TBL] [Abstract] [Full Text] [Related]
8. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
[TBL] [Abstract] [Full Text] [Related]
9. Machine Learning Prediction of Lymph Node Metastasis in Breast Cancer: Performance of a Multi-institutional MRI-based 4D Convolutional Neural Network.
Polat DS; Nguyen S; Karbasi P; Hulsey K; Cobanoglu MC; Wang L; Montillo A; Dogan BE
Radiol Imaging Cancer; 2024 May; 6(3):e230107. PubMed ID: 38607282
[TBL] [Abstract] [Full Text] [Related]
10. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Causes of Death Collaborators
Lancet; 2024 May; 403(10440):2100-2132. PubMed ID: 38582094
[TBL] [Abstract] [Full Text] [Related]
11. Left atrial reservoir longitudinal strain and its incremental value to the left ventricular global longitudinal strain in predicting anthracycline-induced cardiotoxicity.
Li Z; Zhao R; Zhang Q; Shen Y; Shu X; Cheng L
Echocardiography; 2024 Apr; 41(4):e15805. PubMed ID: 38558436
[TBL] [Abstract] [Full Text] [Related]
12. Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.
Park C; Lee HS; Kang KW; Lee WS; Do YR; Kwak JY; Shin HJ; Kim SY; Yi JH; Lim SN; Lee JO; Yang DH; Jang H; Choi B; Lim J; Sun CH; Byun JM; Yoon SS; Koh Y
Nat Commun; 2024 Mar; 15(1):2776. PubMed ID: 38555311
[TBL] [Abstract] [Full Text] [Related]
13. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Fertility and Forecasting Collaborators
Lancet; 2024 May; 403(10440):2057-2099. PubMed ID: 38521087
[TBL] [Abstract] [Full Text] [Related]
14. Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis.
Jung HA; Park B; Park S; Sun JM; Lee SH; Seok Ahn J; Ahn MJ
Lung Cancer; 2024 Apr; 190():107536. PubMed ID: 38493759
[TBL] [Abstract] [Full Text] [Related]
15. Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L; Hirschmann A; Hofman P; Bontoux C; Concha A; Mrabet-Dahbi S; Vannuffel P; Watkin E; Putzová M; Scarpino S; Cayre A; Martin P; Stoehr R; Hartmann A
Virchows Arch; 2024 Apr; 484(4):677-686. PubMed ID: 38492039
[TBL] [Abstract] [Full Text] [Related]
16. Neutrophilic Dermatosis of the Hands: A Case Report.
Yaghoobi R; Bagherani N; R Smoller B; Pazyar N
Acta Dermatovenerol Croat; 2023 Dec; 31(3):148-50. PubMed ID: 38439725
[TBL] [Abstract] [Full Text] [Related]
17. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
[TBL] [Abstract] [Full Text] [Related]
18. Case 322: Pyothorax-associated lymphoma.
Hu JY; Lee KH; Yun G
Radiology; 2024 Feb; 310(2):e223090. PubMed ID: 38411510
[TBL] [Abstract] [Full Text] [Related]
19. Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial.
Xing S; Pu Y; Zhao X; Hu Y; Zhang F; Gu Z; Xu W; Fan L; Miao Y; Li J
Braz J Med Biol Res; 2024; 57():e13284. PubMed ID: 38359273
[TBL] [Abstract] [Full Text] [Related]
20. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
[TBL] [Abstract] [Full Text] [Related]
[Next]
